CVS Health Corporation
CVSHealthcareNASDAQHealthcare Plans · Last scanned Oct 24, 2026
Scan Results
Daily timeframePart of the healthcare sector, CVS Health Corporation (CVS) is listed under Healthcare Plans. The $119.55B market capitalization puts CVS squarely in large-cap range for its industry. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services.
Market Cap
$119.55B
Beta
0.60
P/E (TTM)
24.60
P/E (Fwd)
10.95
EPS (TTM)
$3.80
EPS (Fwd)
$8.54
ROE
6.2%
ROA
3.0%
Cash
$13.96B
Total Debt
$76.31B
Free CF
$8.08B
52W Change
14.1%
Annual Financials
Cash vs Debt
Where CVS stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, CVS finished 0.47% below its 150-day moving average ($90.82) and 3.46% above its 200-day moving average ($87.37). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CVS overbought or oversold?
At the October 15, 2026 close, CVS's RSI(14) was 64.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
CVS Health Corporation carries $76.31B in total debt against $13.96B in cash reserves — debt is roughly 5.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $8.08B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 6.2% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $322.47B (2022) to $402.07B (2025), reflecting a 25% increase over the period.
The relatively low beta of 0.60 suggests CVS is a less volatile holding compared to the broader index. CVS Health Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CVS.